Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Drug Manufacturers - Specialty & Generic


Press Releases

EyePoint Pharmaceuticals Announces Positive Topline Data from the Phase 2 DAVIO 2 Trial of...

  Dec 04, 2023

RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase...

  Dec 04, 2023

HEALWELL AI Completes Acquisition of 'Pentavere', a Leading Healthcare AI and Data Science Company

  Dec 04, 2023

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

  Dec 04, 2023

AMN Healthcare Language Services Partners with ALTA to Offer Unparalleled Language Proficiency...

  Dec 04, 2023

Scilex Holding Company announces the addition of ZTlido® (lidocaine topical system) as a...

  Dec 04, 2023

Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million

  Dec 04, 2023

CorMedix Inc. Announces Partnership With The Leapfrog Group

  Dec 04, 2023

R1 Completes Restatement of Previously Issued Financial Statements

  Dec 04, 2023

Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigationa...

  Dec 04, 2023

The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations...

  Dec 04, 2023

Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule

  Dec 04, 2023

The Joint Corp. to Participate in the 12th Annual Roth Deer Valley Conference

  Dec 04, 2023

IntelGenx Announces Changes to its Board of Directors

  Dec 04, 2023

MIRA Pharmaceuticals Releases Breakthrough Data from Artificial Intelligence Simulations

  Dec 04, 2023

MariMed Commences Operations of Processing Facility in Mt. Vernon, Illinois

  Dec 04, 2023

Spectral Medical Provides November Tigris Trial Update

  Dec 04, 2023

NeuroStar TMS Receives Expanded Regulatory Approval in Japan

  Dec 04, 2023

Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer

  Dec 04, 2023

Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and...

  Dec 04, 2023

Trevena Awarded OLINVYK Agreement with Premier, Inc.

  Dec 04, 2023

Apollomics Presents Interim Data from Two Ongoing Phase 2 Clinical Trials with Vebreltinib in...

  Dec 04, 2023

OKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye...

  Dec 04, 2023

TScan Therapeutics Expands Manufacturing Leadership with the Appointment of Justin McCue, Ph.D.,...

  Dec 04, 2023

OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International...

  Dec 04, 2023

SELLAS Life Sciences Announces Positive Recommendation from REGAL Independent Data Monitoring...

  Dec 04, 2023

Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd...

  Dec 04, 2023

Sunshine Biopharma Moves Principal Office to New York City

  Dec 04, 2023

Viracta Therapeutics Announces Interim Data from Phase 1b/2 Clinical Trial of Nana-val in Patient...

  Dec 04, 2023

Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director

  Dec 04, 2023

Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24

  Dec 04, 2023

AVITA Medical to Host Investor Webinar Briefing

  Dec 04, 2023

INNOVAQOR, INC. PROVIDES UPDATE ON CURALLO PRODUCT AND CONTEMPLATED SHARE EXCHANGE

  Dec 04, 2023

180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives

  Dec 04, 2023

Harvard Apparatus Regenerative Technology and Renowned Professor/Physician Establish a Collaborat...

  Dec 04, 2023

Senhance Robotic System Sold by Asensus Surgical

  Dec 04, 2023

Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson's...

  Dec 04, 2023

GT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ Leukemia

  Dec 04, 2023

CareCloud Welcomes Justin Pierce as Chief Sales Officer

  Dec 04, 2023

Envoy Medical to Host Fireside Chat Event December 7

  Dec 04, 2023

Panbela Announces Publication of Abstract Titled: Evaluation of Myeloma Cell Lines Viability...

  Dec 04, 2023

STRATA Skin Science Announces Strengthening of Leadership Team

  Dec 04, 2023

Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic

  Dec 04, 2023

4DMT to Present Interim 24 Week Data from Randomized Phase 2 PRISM Clinical Trial of 4D-150 in...

  Dec 04, 2023

Cyclerion Appoints Regina Graul, Ph.D., as President

  Dec 04, 2023

Gain Therapeutics to Participate in FORCE Family Office Event with Zacks Small-Cap Research

  Dec 04, 2023

Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc....

  Dec 04, 2023

Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual...

  Dec 04, 2023

Cogent Biosciences to Host Investor Webcast on December 11, 2023 at 8:00 AM ET to Review Clinical...

  Dec 04, 2023

Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual...

  Dec 04, 2023

Tiziana Life Sciences to Present at the Webull LIVE! with Corporate Connect: Biotech Investment...

  Dec 04, 2023

CENTENE CEO SARAH M. LONDON NAMED ONE OF MODERN HEALTHCARE'S 100 MOST INFLUENTIAL PEOPLE

  Dec 04, 2023

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Adicet Bio,...

  Dec 04, 2023

Syndax to Host Investor Event to Discuss Axatilimab and Revumenib Data Updates at 65th ASH Annual...

  Dec 04, 2023

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Acelyrin, Inc. Investors of a Class Action...

  Dec 04, 2023

SHAREHOLDER ALERT: Contact Levi & Korsinsky Before January 22, 2024 to Discuss Your...

  Dec 04, 2023

Inhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001Pro

  Dec 04, 2023

More

Agriculture Building Materials Cannabis Chemicals Coal Communication Services Consumer Cyclical Consumer Defensive Energy Financial Services Forest Products Healthcare Industrials Metals & Mining Gold Industrial Metals & Minerals Silver Real Estate Steel Technology Utilities